Pfizer (PFE), one of the world’s oldest and most respected pharmaceutical companies, is currently facing significant stock ...

Ed Yardeni, a prominent Wall Street bull and founder of Yardeni Research, recently issued a rare warning regarding the ...

According to the latest disclosed 13F filing, nearly 67% of the Bill & Melinda Gates Foundation’s $49 billion investment ...

As of Monday Eastern Time, shares of artificial intelligence (AI) data analytics company Palantir Technologies (PLTR) fell ...

Following the impressive performance of the Toronto Stock Exchange (TSX), which has gained over 21% year-to-date, market ...

In a move that redraws the landscape of the North American gold mining industry, U.S.-based Coeur Mining, Inc. (NYSE: CDE) ...

USA Rare Earth (USAR) stock experienced a significant sell-off on Monday, closing down over 13% and becoming a focal point of ...

Gold prices are consolidating above the critical psychological level of $4,000 an ounce, with major institutions viewing any ...

Netflix, Inc. (NFLX) unveiled plans for a 10-for-1 stock split, its first in ten years, sending its shares higher in the ...

McEwen takes 31% stake in Paragon Geochemical Labs, betting on assay speed and data quality with a focus on PhotonAssay ...

Amazon.com Inc. (AMZN) saw its shares surge in after-hours trading following a stellar third-quarter earnings report that handily surpassed market expectations, signaling a powerful return to form ...

Kimberly-Clark to acquire Kenvue in a 48.7 billion deal, creating a consumer health giant with 32 billion in annual sales, facing market skepticism over pricing, leverage, and promised savings.